Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin plus Temozolomide in MGMT Unmethylated Glioblastoma
NCT06186440Phase 2Not yet recruiting
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Jan 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cisplatin in glioblastoma (GBM), sponsored by Zhongnan Hospital of Wuhan University. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
cisplatin
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT06186440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06186440.